Armephaco JSC

Armephaco JSC EBIT Growth

The Year-over-Year EBIT Growth of Armephaco JSC (AMP.VN) as of Oct 19, 2026 is 95.36 %. In the previous year, Year-over-Year EBIT Growth was -20.39 % — a change of -567.75% (higher).

EBIT Growth

95.36 %

YoY

-567.75%

Last updated:

Year-over-Year EBIT Growth of Armephaco JSC is 2025 95.36 % . Year-over-Year EBIT Growth of Armephaco JSC was 2024 -20.39 % . It decreases by -567.75% higher compared to the previous year.

The Armephaco JSC EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
-26.04 VND
Jan 1, 2019
25.54 VND
Jan 1, 2020
-20.63 VND
Jan 1, 2021
-37.12 VND
Jan 1, 2022
-23.89 VND
Jan 1, 2023
-13.51 VND
Jan 1, 2024
-20.39 VND
Jan 1, 2025
95.36 VND
The Armephaco JSC EBIT Growth history
YEAREBIT GrowthYoY
95.36 %-567.75%
-20.39 %+50.93%
-13.51 %-43.45%
-23.89 %-35.65%
-37.12 %+79.99%
-20.63 %-180.75%
25.54 %-198.08%
-26.04 %-221.18%
21.49 %-37.48%
34.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Year-over-Year EBIT Growth of Armephaco JSC is 95.36 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Armephaco JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Armephaco JSC

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Armephaco JSC